Cancer Stem Cells and Pediatric Solid Tumors
Author Information
Author(s): Friedman Gregory K., Gillespie G. Yancey
Primary Institution: University of Alabama at Birmingham
Hypothesis
Do tumor stem cells exist in pediatric malignancies and do they function similarly to those in adult tumors?
Conclusion
Pediatric solid tumors contain cancer stem cells that exhibit unique properties and therapeutic resistance, necessitating targeted treatment strategies.
Supporting Evidence
- Pediatric cancers are mainly embryonic in origin and differ significantly from adult cancers.
- CD133 is the most common marker used to identify pediatric tumor stem cells.
- Therapies targeting tumor stem cells are being explored to improve treatment outcomes.
Takeaway
Some cancer cells in kids are like special seeds that can grow into more cancer, and they are really tough to kill with regular treatments.
Methodology
The review discusses the identification and characteristics of tumor stem cells in pediatric solid tumors, focusing on their markers, microenvironment, and resistance mechanisms.
Limitations
The review highlights the need for better markers to identify all tumor stem cells and the challenges in studying their microenvironment.
Participant Demographics
The review discusses pediatric patients, specifically mentioning ages from 15 months to six years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website